Carrageenan

角菜酸酯

Report date: 2023/02/25 19:25:15

Base Information

Drug NameCarrageenan
Drug Alias NameLambda-carrageenanCarraguardCarraghenatesPC-515
ClassificationNatural product/Extract
Mechanisms of ActionVirus internalization inhibitors
TargetsNot applicable
Therapy Area/IndicationsHemorrhoidsHerpes SimplexHIV Seropositivity +[9
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryThailandSouth AfricaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPopulation Council, Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesPopulation Council, Inc
Active IndicationsHemorrhoids
Inactive IndicationsHerpes SimplexHIV SeropositivityAcquired Immunodeficiency Syndrome +[8

Other Information

ATC CodeN/A
Related LinksN/A